The fight against breast cancer is tough. It can change how it behaves over time. This makes it hard for doctors to treat. A group of experts in southern Italy came together to find better ways to handle this. They wanted to improve how metastatic breast cancer is managed. The team included oncologists and pathologists. They met twice to discuss and plan. They create...

Imagine you're battling metastatic breast cancer (mBC). You're wondering if a supervised exercise program could do more than just keep you active. Researchers decided to test this idea. They conducted a study called the PREFERABLE-EFFECT trial. This trial compared a 9-month exercise program with usual care, which included general activity advice and an activity track...

Metastatic breast cancer is serious business. It's when cancer spreads from the breast to other parts of the body. There are two main types: hormone receptor-positive (HR+) and triple-negative (TN). For a long time, chemotherapy (CT) has been the standard treatment. But now, antibody-drug conjugates (ADCs) are grabbing attention. These are like smart bombs that targe...

Imagine you're at the doctor's office, trying to figure out which medicine works best for a specific type of breast cancer. Palbociclib and ribociclib are both used to treat HR-positive, HER2-negative metastatic breast cancer, but which one is more effective? A study called OPAL (NCT03417115) tried to answer this question. They looked at how long patients stayed dise...